This is our celebration month!
In these 7 years, we have experimented a lot of things. First of all, we have recruited in our studies about 1.470+ patients. We have more than 20 projects ongoing, and we reach more than 300 ideas from researchers. MedSIR is growing fast and we are very proud to say that we are a totally international company with our new operations office in New York, USA.
At this point, we know that new challenges are right of the corner, but we believe in our dynamic, flexible, out-of-the-box thinking, multifunctional, proactive team of professionals, to achieve new goals. Since its creation, MedSIR has carried out projects in metastatic breast cancer, endometrial cancer, and lung cancer, while in the process of designing trials for a number of other tumors such as prostate and ovarian. The MedSIR concept is now expanding into other pathologies and diseases.
From MedSIR, we would like to thanks to all the persons involved and who helped us to become in what we are today. A huge thank you as well to all the participating centers, study teams, and the individual investigators who have confidently sent us their ideas to develop into better lives for cancer patients.
And, of course, an even bigger thank you to those 1.470+ patients and their families who have put their trust and hope in our many trials. Together we can do more!